Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study

BACKGROUND: Hepatoma arterial-embolization prognostic (HAP) series scores have been proposed for prognostic prediction in patients with unresectable hepatocellular carcinoma (uHCC) undergoing transarterial chemoembolization (TACE). However, their prognostic value in TACE plus sorafenib (TACE-S) rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yejing, Wang, Enxin, Zhao, Shoujie, Han, Dandan, Zhao, Yan, Chen, Hui, Zhu, Jun, Han, Tenghui, Bai, Yang, Lou, Yanju, Zhang, Yongchao, Yang, Man, Zuo, Luo, Fan, Jiahao, Chen, Xing, Jia, Jia, Wu, Wenbin, Ren, Weirong, Bai, Tingting, Ma, Shouzheng, Xu, Fenghua, Tang, Yuxin, Han, Ying, Zhao, Junlong, Qi, Xingshun, Li, Jing, Du, Xilin, Chen, Dongfeng, Liu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911813/
https://www.ncbi.nlm.nih.gov/pubmed/36776366
http://dx.doi.org/10.3389/fonc.2022.983554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911813/
https://www.ncbi.nlm.nih.gov/pubmed/36776366
http://dx.doi.org/10.3389/fonc.2022.983554

Ejemplares similares